These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 984771)

  • 1. In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins.
    Blackwell CC; Freimer EH; Tuke GC
    Antimicrob Agents Chemother; 1976 Aug; 10(2):288-92. PubMed ID: 984771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria.
    Shadomy S; Wagner G; Carver M
    Antimicrob Agents Chemother; 1977 Nov; 12(5):609-13. PubMed ID: 921258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640).
    Stilwell GA; Adams HG; Turck M
    Antimicrob Agents Chemother; 1975 Dec; 8(6):751-3. PubMed ID: 813573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.
    Overturf GD; Ressler RL; Marengo PB; Wilkins J
    Antimicrob Agents Chemother; 1975 Sep; 8(3):305-10. PubMed ID: 1167042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefatrizine activity compared with that of other cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):209-12. PubMed ID: 426514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin.
    Actor P; Uri JV; Phillips L; Sachs CS; Guarini JR; Zajac I; Berges DA; Dunn GL; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1975 Aug; 28(8):594-601. PubMed ID: 808525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Haemophilus influenzae type b to cefatrizine, ampicillin, and chloramphenicol.
    Brotherton T; Lees T; Feigin RD
    Antimicrob Agents Chemother; 1976 Aug; 10(2):322-4. PubMed ID: 1086634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.
    Watanakunakorn C; Bannister T; Glotzbecker C
    Antimicrob Agents Chemother; 1975 Mar; 7(3):381-5. PubMed ID: 1137392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of BMY-28100, a new oral cephalosporin.
    Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro activity of several cephalosporin antibiotics against gram-negative and gram-positive bacteria resistant to cephaloridine.
    Kisch AL; Bartholomew L
    Antimicrob Agents Chemother; 1976 Sep; 10(3):507-10. PubMed ID: 984793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative inhibitory activity of BL-S640 and two other cephalosporins.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    J Antibiot (Tokyo); 1975 Aug; 28(8):590-3. PubMed ID: 239917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and clinical studies of cefatrizine, a new semisynthetic cephalosporin.
    del Busto R; Haas E; Madhaven T; Burch K; Cox F; Fisher E; Quinn E; Pohlod D
    Antimicrob Agents Chemother; 1976 Mar; 9(3):397-405. PubMed ID: 1259399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of ceftazidime against clinically important pathogens.
    Knothe H; Dette GA
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP; Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.